ETSA winner Theranautilus heads to human trials; JSW One’s IPO plans
Happy Friday! Theranautilus is set to begin human trials of its nanorobot-based dental tech soon.
This and more in today’s ETtech Morning Dispatch.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on economictimes.indiatimes.com — the content belongs to Economic Times - Tech.
